| Literature DB >> 33817447 |
Sinéad A Coleman1, Conal J Cunningham2, Niamh Murphy1, Jean Feaheny1, David Robinson2, Rosaleen Lannon2, Kevin McCarroll2, Miriam Casey2, Joseph Harbison2, N Frances Horgan3.
Abstract
OBJECTIVES: Progressive resistance training can successfully target functional decline in healthy older community-dwelling adults. There are concerns about the safety and acceptance of its use in frail older populations. The aim of this study was to evaluate the feasibility of using progressive resistance training in an older, post-acute, inpatient setting.Entities:
Keywords: Older inpatients; Progressive resistance training
Year: 2021 PMID: 33817447 PMCID: PMC8017350 DOI: 10.22540/JFSF-06-014
Source DB: PubMed Journal: J Frailty Sarcopenia Falls ISSN: 2459-4148
Figure 1CONSORT diagram demonstrating patient flow through the study.
Baseline demographic data and clinical characteristics of participants (n=33)
| Characteristic | CON (n=17) N (%) | PRT (n=16) N (%) | |
|---|---|---|---|
| Gender | Male | 8 (47.1) | 8 (50.0) |
| Age | Median age | 82.7 (6.3) | 83.1 (6.1) |
| Presenting diagnosis | Falls | 5 (29) | 10 (62) |
| Mobility on admission to rehabilitation | IND | 0 (0) | 0 (0) |
| IND + walking stick | 1 (6) | 1 (6) | |
| IND + walking frame | 4 (23) | 4 (25) | |
| Supervision | 9 (53) | 5 (31) | |
| Assistance | 3 (18) | 6 (38) | |
| Transfers on admission to rehabilitation | IND | 7 (41) | 4 (25) |
| Supervision | 4 (23) | 7 (44) | |
| Assistance | 6 (34) | 5 (31) | |
| Social History | Lives alone | 10 (58.8) | 10 (62.5) |
| Lives with family | 5 (29.4) | 6 (37.5) | |
| Other | 2 (11.8) | 0 (0) | |
| Grip (R) | 12.69 (7.37) | 13.87 (6.56) | |
| Grip (L) | 11.29 (7.15) | 11.2 (5.58) | |
| HA (R) | 5.77 (2.35) | 4.97 (2.44) | |
| HA (L) | 5.25 (1.45) | 4.92 (2.29) | |
| HF (R) | 5.48 (2.63) | 4.54 (1.66) | |
| HF (L) | 4.89 (1.41) | 4.71 (1.93) | |
| HE (R) | 6.12 (2.08) | 6.19 (2.65) | |
| HE (L) | 6.24 (2.08) | 6.19 (2.39) | |
| KE (R) | 5.55 (2.34) | 5.2 (2.15) | |
| KE (L) | 5.35 (1.99) | 5.33 (2.31) | |
| AP (R) | 6.09 (3.36) | 4.77 (2.21) | |
| AP (L) | 5.36 (2.26) | 4.64 (2.38) | |
| AD (R) | 4.33 (2.48) | 3.52 (1.67) | |
| AD (L) | 4.04 (1.75) | 3.11 (1.54) | |
| Comorbidities | 5.4 (2.1) | 3.3 (1.5) | |
| BMI | 23.19 (3.31) | 24.65 (3.61) | |
| Muscle Mass (KG) | 42.19 (8.85) | 46.97 (6.71) | |
| TUG (s) | 46.03 (29.35) | 57.18 (29.22) | |
| SNT Ascent (s) | 16.04 (16.3) | 13.13 (5.14) | |
| SNT Descent (s) | 18.11 (16.71) | 15.74 (6.09) | |
| CFS (/9) | 5.35 (1.27) | 5.62 (1.09) | |
| EQ-5D VAS (/100) | 50 (22.64) | 61.87 (20.89) |
CON=control group, PRT=progressive resistance training group, IND=independent, SD=standard deviation, KG=kilograms, (R)=Right, (L)=left, HA=hip abduction, HF=hip flexion, HE=hip extension, KE=knee extension, AP=ankle plantarflexion, AD=ankle dorsiflexion, BMI=body mass index, TUG=Timed Up and Go, s=seconds, SNT=Stair Negotiation Test, CFS=Clinical Frailty Scale, EQ-5D VAS=EuroQol 5D Visual Analogue Scale.
Discharge destination of participants.
| Discharge Destination | CON (n=17) N (%) | PRT (n=16) N (%) |
|---|---|---|
| Home | 5 (29.4) | 3 (18.8) |
| Home with follow-up in Primary Care | 5 (29.4) | 6 (37.5) |
| Long Term Care | 2 (11.8) | 5 (31.3) |
| Other hospital | 2 (11.8) | 0 (0) |
| Deceased | 3 (17.6) | 2 (12.5) |
CON=control group, PRT=progressive resistance training group.
Changes in grip strength and LL dynamometry, skeletal muscle mass, TUG, SNT, CFS and EQ-5D VAS from initial to final assessment (n=27).
| Dynamometry (KG) | CON=13 PRT=14 | T1 Median (Min, Max) | T2 Median (Min, Max) | T2-T1 Median (Min, Max) | p |
|---|---|---|---|---|---|
| Grip (R) | CON | 9.8 (3.5, 29.3) | 12 (5, 29) | 1.40 (-6.00,4.70) | 0.681 |
| PRT | 15.7 (2, 22.7) | 14.3 (2, 25.7) | 0.70 (-7.70,7.30) | ||
| Grip (L) | CON | 10.7 (2, 25.7) | 9.7 (3.3, 25.7) | 1.30 (-5.30,6.70) | 0.472 |
| PRT | 12.7 (1.7, 23.3) | 14.3 (3.3, 17) | 0.30 (-9.00,8.00) | ||
| HA (R) | CON | 6.1 (2.5, 9.9) | 4.5 (3.1, 12.1) | 0.90 (-2.70,5.10) | 0.234 |
| PRT | 4.55 (1.6, 9.7) | 6.35 (2.5, 11.8) | 1.45 (-1.40,7.30) | ||
| HA (L) | CON | 5.1 (2.8, 7.5) | 4.1 (2.3, 9.3) | 0.20 (-2.60,3.40) | 0.382 |
| PRT | 4.7 (1.4, 9.1) | 5.4(2.5, 10.8) | 0.40 (-2.50,5.50) | ||
| HF (R) | CON | 4.5 (2.3, 12.3) | 4.4 (2.7, 11) | 0.40 (-9.10,3.40) | 0.645 |
| PRT | 4.3 (1.9, 8.4) | 4.95 (2.7, 9.9) | 0.7 (-3.8, 2.7) | ||
| HF (L) | CON | 4.3 (2.8, 7.4) | 4.6 (2.5, 8.2) | 0.1 (-1.3, 2.6) | 0.645 |
| PRT | 4.5 (2.2, 9.5) | 5.05 (3.1, 7.8) | 0.8 (-3.4, 3.4) | ||
| HE (R) | CON | 5.7 (3.5, 10.6) | 6.4 (4.4, 10.6) | 0.6 (-3.6, 4.8) | 0.512 |
| PRT | 6 (2, 10.6) | 7.05 (2.5, 11) | 1.3 (-5.8, 5.4) | ||
| HE (L) | CON | 5.5 (3.1, 10.5) | 5.8 (4.2, 10.3) | -0.6 (-3.4, 3.5) | 0.099 |
| PRT | 6.2 (2, 10.8) | 7.05 (3.4, 11.3) | 0.3 (-2.1, 4.9) | ||
| KE (R) | CON | 5.6(2, 9.5) | 5.7 (2.3, 11.7) | 0.5 (-2.8, 4.2) | 0.752 |
| PRT | 5.35 (1.9, 9.9) | 5.7 (2.7, 10.5) | 0.2 (-3.1, 3.8) | ||
| KE (L) | CON | 5 (1.6, 8.2) | 5.3 (3, 11.1) | 0.2 (-1.6, 3.5) | 0.789 |
| PRT | 5.5 (1.8, 10.6) | 5.7 (2.5, 10.5) | 0.2 (-3.2, 3.5) | ||
| AP (R) | CON | 4.7 (2.1, 15.4) | 4 (1.9, 10.9) | -0.9 (-4.5, 2.6) | 0.207 |
| PRT | 3.9 (2, 9.4) | 5 (1.7,11) | -0.3 (-21, 4.3) | ||
| AP (L) | CON | 4.2 (2.9, 10.7) | 5 (1.9, 10.5) | -0.2 (-3.7, 4.4) | 0.544 |
| PRT | 4 (1.6, 10.7) | 4.3 (2.5, 10) | -0.2 (-2.3, 3.8) | ||
| AD (R) | CON | 3.4 (1.8, 10.6) | 3.8 (2.1, 9.4) | -0.3 (-1.9, 1.9) | 0.697 |
| PRT | 3 (1.9, 7.3) | 3.7 (1.8, 6.8) | -0.1 (-3.8, 3.9) | ||
| AD (L) | CON | 3.6 (1.8, 8.1) | 3.6 (2, 7.6) | -0.3 (-3.6, 1.6) | 0.027* |
| PRT | 2.65(1.6, 7.1) | 4.1 (2, 7) | 0.7 (-1.2, 3.3) | ||
| Skeletal Muscle Mass (KG) | CON | 39.9 (31.7, 60.7) | 38.8 (31.9, 48) | 0 (-11.5, 14.1) | 0.655 |
| PRT | 45.5 (35.6, 55.4) | 44.1 (38.5, 54.6) | 0.4 (-3.9, 2.9) | ||
| TUG (s) | CON | 37.96 (17.13, 129) | 32 (17.2, 104) | -12.4(-60.8,51.6) | 0.923 |
| PRT | 49.82 (22.2, 125) | 31.42(18.95,136) | -12.8(-74.3,59.0) | ||
| SNT Ascent (s) | CON | 13 (3.1, 70) | 7.7 (4, 22.6) | -2.7 (-62.1, 6.3) | 0.734 |
| PRT | 11.6 (6.1, 25.93) | 7.16 (4.15,20.62) | -4.9 (-11.6, 4.7) | ||
| SNT Descent (s) | CON | 13.45 (4.9, 75) | 10.2 (3.58, 25) | -2.7 (-64.8, 16.1) | 0.961 |
| PRT | 15.11 (7, 32.2) | 8.45 (5.3, 42.7) | -4.8 (-15.5, 22.7) | ||
| CFS (/9) | CON | 6 (3, 7) | 5 (3, 7) | 0 (-1, 0) | 0.550 |
| PRT | 6 (4, 7) | 5 (4, 6) | 0 (-2, 1) | ||
| EQ-5D VAS (/100) | CON | 50 (0, 90) | 60 (50, 90) | 10(-20,60) | 0.156 |
| PRT | 60 (30, 100) | 70 (40, 100) | 0 (-25, 55) |
T1=Assessments at entry to the study, T2=Assessment at six weeks, CON=control group, PRT=progressive resistance training group, (R)=Right, (L)=left, KG=kilograms, HA=hip abduction, HF=hip flexion, HE=hip extension, KE=knee extension, AP=ankle plantarflexion, AD=ankle dorsiflexion, s=seconds, TUG=Timed Up and Go, SNT=Stair Negotiation Test, CFS=Clinical Frailty Scale, EQ-5D VAS=EuroQol 5D Visual Analogue Scale.